Pharmaceutical composition for preventing or treating arthritis

    公开(公告)号:US10434135B2

    公开(公告)日:2019-10-08

    申请号:US15556963

    申请日:2016-03-14

    摘要: A pharmaceutical composition for preventing or treating arthritis, which comprises synthetic polypeptides; injections for preventing or treating arthritis; and a pharmaceutical composition for inducing differentiation of cartilage cells are described herein. Synthetic polypeptides of the present invention consisting of a polypeptide represented by SEQ ID NO: 1 and a polypeptide represented by SEQ ID NO: 2 have activity for recruiting stem cells to an arthritis region, inhibit apoptosis of cartilage cells, and exhibit anti-inflammatory activity and activity for promoting regeneration of cartilage cells. Thus, unlike a conventional arthritis treatment agent, the synthetic polypeptides can improve cartilage damage, can inhibit degenerative changes per se and can, at the same time, exhibit an effect as a stem cell treatment agent, and thereby can be usefully utilized as an arthritis prevention or treatment agent.

    PREPARATION METHOD OF FLEXIBLE POLYLACTIDE STEREOCOMPLEX AND THE COMPOUND THEREOF
    2.
    发明申请
    PREPARATION METHOD OF FLEXIBLE POLYLACTIDE STEREOCOMPLEX AND THE COMPOUND THEREOF 审中-公开
    柔性聚合物立体异构体及其化合物的制备方法

    公开(公告)号:US20150057385A1

    公开(公告)日:2015-02-26

    申请号:US14519841

    申请日:2014-10-21

    IPC分类号: C08G63/08 C08J9/28

    摘要: Disclosed are a polylactide stereocomplex with improved thermal stability and thus improved processability and a method for preparing the same. In order to confer flexibility to polymer chains, D-type polylactide polymer containing a small amount of caprolactone (poly D-lactide-caprolactone copolymer) is synthesized and it is uniformly mixed with L-type single-phase polylactide to prepare a flexible polylactide stereocomplex. Since the polylactide stereocomplex having flexible polymer chains has superior heat resistance and mechanical stability and experiences little decrease of the degree of stereocomplex formation even after thermal processing, the polylactide stereocomplex having improved thermal stability can be advantageously used for engineering plastics requiring high strength and good thermal stability, alternative materials for general-use plastics, high-performance medical materials, or the like because of its remarkably improved processability.

    摘要翻译: 公开了具有改进的热稳定性和因此改善的加工性的聚交酯立体络合物及其制备方法。 为了赋予聚合物链柔性,合成含有少量己内酯(聚D-丙交酯 - 己内酯共聚物)的D型聚丙交酯聚合物,并将其与L型单相聚丙交酯均匀混合以制备柔性聚交酯立体络合物 。 由于具有柔性聚合物链的聚交酯立体络合物具有优异的耐热性和机械稳定性,并且即使在热加工后也几乎不降低立体复合物形成程度,所以具有改善的热稳定性的聚交酯立体络合物可有利地用于需要高强度和良好热的工程塑料 稳定性,一般用途塑料的替代材料,高性能医疗材料等,因为其显着改进的加工性能。

    Preparation method of hydrogel based on decellularized tissue using supercritical fluid-organic solvent system

    公开(公告)号:US10537663B2

    公开(公告)日:2020-01-21

    申请号:US15800436

    申请日:2017-11-01

    摘要: A method for preparing a decellularized tissue-based hydrogel with maximized ability of preserving various tissue-derived proteins, growth factors and cytokines by using a supercritical fluid-organic solvent system through (a) a step of decellularizing a biological tissue by bringing the same to contact with a supercritical fluid and an organic solvent at the same time; (b) a step of washing the decellularized tissue; (c) a step of preparing a decellularized tissue solution by mixing the washed decellularized tissue with one selected from an enzyme solution, an acidic solution and a mixture thereof; (d) a step of titrating the decellularized tissue solution to pH 5.5-7.8 by treating with a basic solution; and (e) a step of allowing the titrated decellularized tissue solution to stand at 30-40° C. and utilizing the same as a tissue engineering material with improved angiogenesis and tissue regeneration abilities.

    Method for preparing poly(L-lactic acid) composite

    公开(公告)号:US10287392B2

    公开(公告)日:2019-05-14

    申请号:US15717212

    申请日:2017-09-27

    摘要: Disclosed is a method for preparing a poly(L-lactic acid) composite. According to the method, PLLA can be processed without losing its physical properties during thermal processing and can be effectively used to manufacture a final product with improved thermal properties. In addition, the monomer is not thermally decomposed during high-temperature polymerization. Therefore, the poly(L-lactic acid) composite can be prevented from browning. Also disclosed is a poly(L-lactic acid) composite prepared by the method.

    Solid-state drawing method for preparing a surgical suture or a biodegradable stent

    公开(公告)号:US10722388B2

    公开(公告)日:2020-07-28

    申请号:US15716620

    申请日:2017-09-27

    摘要: A solid-state drawing method for preparing a surgical suture or a biodegradable stent having improved flexibility and mechanical strength. The method for preparing a biodegradable stent includes (a) providing a biodegradable filament that comprises a material which is biodegradable; (b) solid-state drawing the biodegradable filament to provide a drawn biodegradable filament; (c) shaping the drawn biodegradable filament to provide a shaped biodegradable filament; and (d) annealing the shaped biodegradable filament to provide the biodegradable stent, wherein the biodegradable filament has a draw ratio that ranges from 1.1 to 5.0; and wherein the draw ratio is calculated by Equation 1 below: Draw ratio=(LSSD/LO)2, where LO is length of the biodegradable filament before the solid-state drawing, and LSSD is the length of the biodegradable filament after the solid-state drawing.